SG47049A1 - Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit - Google Patents

Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit

Info

Publication number
SG47049A1
SG47049A1 SG1996004387A SG1996004387A SG47049A1 SG 47049 A1 SG47049 A1 SG 47049A1 SG 1996004387 A SG1996004387 A SG 1996004387A SG 1996004387 A SG1996004387 A SG 1996004387A SG 47049 A1 SG47049 A1 SG 47049A1
Authority
SG
Singapore
Prior art keywords
protein
purification
reagent kit
strains
ccus
Prior art date
Application number
SG1996004387A
Other languages
English (en)
Inventor
Gunnar Lindahl
Margareth Stalhammar-Carlemalm
Lars Stenber
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Publication of SG47049A1 publication Critical patent/SG47049A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG1996004387A 1993-03-19 1994-03-21 Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit SG47049A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19

Publications (1)

Publication Number Publication Date
SG47049A1 true SG47049A1 (en) 1998-03-20

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004387A SG47049A1 (en) 1993-03-19 1994-03-21 Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit

Country Status (17)

Country Link
US (1) US5869064A (da)
EP (1) EP0656014B1 (da)
JP (1) JP3976334B2 (da)
KR (1) KR100331358B1 (da)
CN (1) CN1046291C (da)
AT (1) ATE240351T1 (da)
CA (1) CA2158658A1 (da)
DE (1) DE69432658T2 (da)
DK (1) DK0656014T3 (da)
ES (1) ES2194024T3 (da)
HU (1) HU217582B (da)
NZ (1) NZ263275A (da)
PT (1) PT656014E (da)
SG (1) SG47049A1 (da)
SI (1) SI0656014T1 (da)
WO (1) WO1994021685A1 (da)
ZA (1) ZA941958B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
CA2321106C (en) 1998-02-20 2013-07-23 Biochem Pharma Inc. Group b streptococcus antigens
CN101066447A (zh) * 1998-12-22 2007-11-07 微科学有限公司 基因和蛋白质,及它们的用途
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
CA2354843A1 (en) 1998-12-22 2000-06-29 Microscience Limited Outer surface proteins, their genes, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
KR100802198B1 (ko) * 1998-12-23 2008-02-11 샤이어 바이오켐 인코포레이티드 신규한 스트렙토코커스 항원
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
WO2002099133A1 (fr) * 2001-05-31 2002-12-12 Fuso Pharmaceutical Industries, Ltd. Procede ameliore de detection et d'identification de micro-organismes causes d'infections
JPWO2002101037A1 (ja) * 2001-05-31 2005-04-07 扶桑薬品工業株式会社 食細胞機能の評価方法およびその利用
ES2381967T3 (es) * 2002-02-11 2012-06-04 Id Biomedical Corporation Antígeno de streptococcus del grupo B
EP1845944A4 (en) * 2005-02-08 2011-07-27 Id Biomedical Corp Of Quebec C O B As Glaxosmithkline Biolog North America PHARMACEUTICAL COMPOSITIONS
SI2144924T1 (sl) * 2007-04-16 2016-12-30 Minervax Aps Cepivo s fuzijskimi beljakovinami
CN108135992A (zh) 2015-10-21 2018-06-08 米纳瓦克斯有限责任公司 免疫原性融合蛋白
US10888610B2 (en) 2015-12-30 2021-01-12 Minerv Ax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
EP3638301A1 (en) 2017-06-16 2020-04-22 GlaxoSmithKline Biologicals S.A. Method of treatment
US12533418B2 (en) 2019-11-22 2026-01-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (en) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
JPH06506114A (ja) * 1991-03-29 1994-07-14 ファウルマン，　エルビン 新規な遺伝子及びＩｇＡ結合蛋白質の製造方法

Also Published As

Publication number Publication date
US5869064A (en) 1999-02-09
JPH09500092A (ja) 1997-01-07
JP3976334B2 (ja) 2007-09-19
CA2158658A1 (en) 1994-09-29
KR960701096A (ko) 1996-02-24
ES2194024T3 (es) 2003-11-16
KR100331358B1 (ko) 2002-08-13
WO1994021685A1 (en) 1994-09-29
EP0656014A1 (en) 1995-06-07
AU6389194A (en) 1994-10-11
EP0656014B1 (en) 2003-05-14
PT656014E (pt) 2003-09-30
DK0656014T3 (da) 2003-08-11
CN1119442A (zh) 1996-03-27
HU9501993D0 (en) 1995-08-28
DE69432658T2 (de) 2004-04-08
HUT72841A (en) 1996-05-28
ATE240351T1 (de) 2003-05-15
SI0656014T1 (en) 2003-12-31
AU681130B2 (en) 1997-08-21
HK1008825A1 (en) 1999-05-21
NZ263275A (en) 1997-07-27
ZA941958B (en) 1995-01-27
DE69432658D1 (de) 2003-06-18
CN1046291C (zh) 1999-11-10
HU217582B (hu) 2000-02-28

Similar Documents

Publication Publication Date Title
SG47049A1 (en) Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
IL193886A0 (en) Antibodies that bind to ldcam sequences
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
AU1026692A (en) Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
ZA933216B (en) Recombinant DNA molecules encoding aminopeptidas enzymes and their use in the preparation of vaccines against helminth infections
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
CA2192940A1 (en) Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
AU676859B2 (en) Synthetic peptides, antibodies against them and their use
WO1999015666A3 (en) Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
CA2093427A1 (en) Molecular clones of hiv-1 and uses thereof
DE69737413D1 (en) Bakterioferritin aus helicobacter pylori
GB9409985D0 (en) Vaccine against mycobacterial infections
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
WO1995011919A3 (de) REKOMBINANTE PilC-PROTEINE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG
HUP0104825A2 (hu) Gének, fehérjék és alkalmazásuk
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
Schmidt et al. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
WO2000024765A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO1990012807A3 (en) Purified, highly specific antibodies against gene products including retinoblastoma and method
ZA200007619B (en) New peptide fragments for protein purification.